PT1673361E - Método para o fabrico de lovastatina - Google Patents
Método para o fabrico de lovastatina Download PDFInfo
- Publication number
- PT1673361E PT1673361E PT03782759T PT03782759T PT1673361E PT 1673361 E PT1673361 E PT 1673361E PT 03782759 T PT03782759 T PT 03782759T PT 03782759 T PT03782759 T PT 03782759T PT 1673361 E PT1673361 E PT 1673361E
- Authority
- PT
- Portugal
- Prior art keywords
- lovastatin
- manufacture
- impure
- lactonisation
- repurification
- Prior art date
Links
- QLJODMDSTUBWDW-UHFFFAOYSA-N lovastatin hydroxy acid Natural products C1=CC(C)C(CCC(O)CC(O)CC(O)=O)C2C(OC(=O)C(C)CC)CC(C)C=C21 QLJODMDSTUBWDW-UHFFFAOYSA-N 0.000 title abstract 6
- PCZOHLXUXFIOCF-UHFFFAOYSA-N Monacolin X Natural products C12C(OC(=O)C(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 PCZOHLXUXFIOCF-UHFFFAOYSA-N 0.000 title abstract 5
- PCZOHLXUXFIOCF-BXMDZJJMSA-N lovastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 PCZOHLXUXFIOCF-BXMDZJJMSA-N 0.000 title abstract 5
- 229960004844 lovastatin Drugs 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- QLJODMDSTUBWDW-BXMDZJJMSA-N mevinolinic acid Chemical compound C1=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@H]2[C@@H](OC(=O)[C@@H](C)CC)C[C@@H](C)C=C21 QLJODMDSTUBWDW-BXMDZJJMSA-N 0.000 abstract 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 abstract 1
- 238000002955 isolation Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/30—Oxygen atoms, e.g. delta-lactones
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pyrane Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IN2003/000333 WO2005035515A1 (en) | 2003-10-14 | 2003-10-14 | A method for the manufacture of lovastatin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1673361E true PT1673361E (pt) | 2009-07-13 |
Family
ID=34430672
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT03782759T PT1673361E (pt) | 2003-10-14 | 2003-10-14 | Método para o fabrico de lovastatina |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7566792B2 (pt) |
| EP (1) | EP1673361B1 (pt) |
| AT (1) | ATE432270T1 (pt) |
| AU (1) | AU2003290396A1 (pt) |
| CA (1) | CA2540068C (pt) |
| DE (1) | DE60327813D1 (pt) |
| ES (1) | ES2325498T3 (pt) |
| PT (1) | PT1673361E (pt) |
| WO (1) | WO2005035515A1 (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102993145B (zh) * | 2011-09-19 | 2015-06-03 | 北大方正集团有限公司 | 一种提取纯化洛伐他汀的方法 |
| EP2597092A1 (en) * | 2011-11-24 | 2013-05-29 | Sterling Biotech Limited | A process for purification of lovastatin |
| CN111718317A (zh) * | 2019-03-21 | 2020-09-29 | 福安药业集团烟台只楚药业有限公司 | 一种洛伐他汀的提炼方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69614571T2 (de) | 1995-12-06 | 2002-06-27 | Balkanpharma Razgard Ad Razgar | Verfahren zur herstellung von lovastatin |
| PL346392A1 (en) | 1999-06-29 | 2002-02-11 | Kaneka Corp | Process for selective lactonization |
| CA2388182A1 (en) | 1999-10-27 | 2001-05-03 | Merck & Co., Inc. | Lactonization process |
| IN192861B (pt) * | 2000-06-30 | 2004-05-22 | Ranbaxy Lab Ltd |
-
2003
- 2003-10-14 ES ES03782759T patent/ES2325498T3/es not_active Expired - Lifetime
- 2003-10-14 WO PCT/IN2003/000333 patent/WO2005035515A1/en active Application Filing
- 2003-10-14 US US10/571,192 patent/US7566792B2/en not_active Expired - Fee Related
- 2003-10-14 PT PT03782759T patent/PT1673361E/pt unknown
- 2003-10-14 DE DE60327813T patent/DE60327813D1/de not_active Expired - Lifetime
- 2003-10-14 AU AU2003290396A patent/AU2003290396A1/en not_active Abandoned
- 2003-10-14 AT AT03782759T patent/ATE432270T1/de not_active IP Right Cessation
- 2003-10-14 EP EP03782759A patent/EP1673361B1/en not_active Expired - Lifetime
- 2003-10-14 CA CA2540068A patent/CA2540068C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2540068C (en) | 2012-05-29 |
| US7566792B2 (en) | 2009-07-28 |
| CA2540068A1 (en) | 2003-10-14 |
| ATE432270T1 (de) | 2009-06-15 |
| ES2325498T3 (es) | 2009-09-07 |
| EP1673361A1 (en) | 2006-06-28 |
| EP1673361B1 (en) | 2009-05-27 |
| AU2003290396A1 (en) | 2005-04-27 |
| DE60327813D1 (de) | 2009-07-09 |
| WO2005035515A1 (en) | 2005-04-21 |
| US20070238885A1 (en) | 2007-10-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003294723A1 (en) | Process for the purification of crude propene oxide | |
| BRPI0410685A (pt) | processos de purificação de 1,3-propanodiol e composições | |
| PL369740A1 (en) | Novel dihydropteridinones, method for producing the same and the use thereof as medicaments | |
| MXPA05009969A (es) | Metodo para aislar la forma cristalina i de la 5-azacitidina. | |
| WO2005062897A3 (en) | Polymorphs of ezetimibe and processes for the preparation thereof | |
| IL172015A0 (en) | Pyrimidine compounds having phosphonate groups as antiviral nucleotide analogs | |
| MY138263A (en) | Therapeutic chroman compounds | |
| WO2006066044A3 (en) | Processes for producing 4-aminoquinazolines | |
| AU2003293585A1 (en) | Intermediate cefdinir salts | |
| MX2007002808A (es) | Proceso para el aislamiento de tacrolimus cristalino. | |
| AU2003293042A1 (en) | Process for purification of plasmid dna | |
| AU2001272504A1 (en) | 4-alkoxy cyclohexane-1 amino carboxylic acid esters and method for the production thereof | |
| AU2002356978A1 (en) | Method of separating compound(s) from mixture(s) | |
| AU2003255483A1 (en) | Process for the conversion of polysulfanes | |
| HUP0401006A2 (hu) | Eljárás 7-amino-szin-3,5-dihidroxi-heptánsav-származékok előállítására, ezek köztitermékei és módszerek az előállításukra | |
| AU2003279186A1 (en) | Process of purifying phosphoramidites | |
| PT1673361E (pt) | Método para o fabrico de lovastatina | |
| GB0327323D0 (en) | Novel pharmaceuticals | |
| AU2001260305A1 (en) | Method for discontinuous purification of crude acrylic acid by means of crystallization | |
| EP1443053A4 (en) | ANALGETIC ANTITUMORPEPTIDE FROM SCORPIONES AND METHOD FOR THE PRODUCTION THEREOF | |
| AU2001244649A1 (en) | Method for purification of cyclic ester | |
| WO2004013282A3 (en) | Bis (amino acid) molecular scaffolds | |
| WO2005054175A3 (en) | New process for the preparation of nitrooxyderivatives of paracetamol | |
| AU2002247949A1 (en) | Process for synthesis of trans-alkenoic acid, use thereof | |
| AU2003219423A1 (en) | Process for the isolation of high purity crystalline citalopram base |